OI-302

N/A

Report date: 2025/01/26 16:03:04

Base Information

Drug NameOI-302
Drug Alias NameCAR macrophage therapy (Oncoinsight/JW Creagene)CAR allogeneic iPSC-derived macrophages therapy (Oncoinsight/Jw Creagene)OI-302
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapy
Mechanisms of ActionMacrophages stimulantsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoinsight Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOncoinsight Co LtdJw Creagene Corp
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A